Endothelial dysfunction in hypertension: the role of arginase

Area of Science:

• Cardiovascular Science
• Vascular Biology
• Hypertension Research

Background:

• Essential hypertension is a leading global cause of mortality, with many patients exhibiting uncontrolled or treatment-resistant disease.
• Hypertension and related cardiovascular diseases often lead to endothelial dysfunction and inflammation.
• The endothelium, crucial for vascular tone and hemostasis, is increasingly recognized for its role in hypertension pathogenesis.

Purpose of the Study:

• To explore the role of endothelial dysfunction in hypertension.
• To investigate specific molecular pathways involved in hypertension-related endothelial dysfunction, including nitric oxide and arginase.
• To identify potential alternative therapeutic targets for hypertension complications.

Main Methods:

• Review of current literature on hypertension, endothelial function, and molecular pathways.
• Analysis of the role of nitric oxide (NO) bioavailability in hypertension.
• Examination of the involvement of reactive oxygen species (ROS) and the enzyme arginase in endothelial dysfunction.

Main Results:

• Endothelial dysfunction is a key feature of hypertension, contributing to inflammation and altered vascular function.
• Impaired nitric oxide (NO) production and increased reactive oxygen species (ROS) are significant contributors to endothelial dysfunction.
• Elevated arginase activity, linked to the L-arginine-urea cycle, is implicated as a potential factor in hypertension.

Conclusions:

• Endothelial dysfunction, driven by pathways like NO impairment and increased arginase, plays a critical role in hypertension.
• These molecular pathways represent promising targets for novel therapeutic strategies.
• Alternative treatments focusing on endothelial function may complement or surpass conventional blood pressure-lowering therapies.